This is a demo store. No orders will be fulfilled.

Atorvastatin Calcium Salt Trihydrate - 97%, high purity , CAS No.344423-98-9

    Grade & Purity:
  • ≥97%
In stock
Item Number
A179410
Grouped product items
SKU Size
Availability
Price Qty
A179410-1g
1g
3
$240.90
A179410-5g
5g
3
$823.90
A179410-25g
25g
2
$2,746.90
View related series
Lipid metabolism (1912)

Basic Description

Synonyms Calcium(3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoatetrihydrate | 344423-98-9 (calcium trihydrate) | Lipitor, Atorvastatin calcium trihydrate | Ocustatin component atorvastatin calcium trihyd
Specifications & Purity ≥97%
Storage Temp Store at 2-8°C
Shipped In
Wet ice
This product requires cold chain shipping. Ground and other economy services are not available.
Product Description

Atorvastatin Calcium, off white crystalline powder. It is a synthetic selective inhibitor of HMG-CoA reductase. It is insoluble in aqueous solution with pH below 4 and is freely soluble in methanol.
It was used as standard in the method development and validation for simultaneous determination of Atorvastatin calcium and Ezetimibe in tablets using UV spectrophotometric, HPLC and HPTLC methods.

Taxonomic Classification

Taxonomy Tree

Kingdom Organic compounds
Superclass Organoheterocyclic compounds
Class Pyrroles
Subclass Substituted pyrroles
Intermediate Tree Nodes Phenylpyrroles
Direct Parent Diphenylpyrroles
Alternative Parents Aromatic anilides  Medium-chain hydroxy acids and derivatives  Pyrrole carboxamides  Medium-chain fatty acids  Beta hydroxy acids and derivatives  Fluorobenzenes  Hydroxy fatty acids  Aryl fluorides  Vinylogous amides  Heteroaromatic compounds  Secondary carboxylic acid amides  Secondary alcohols  Carboxylic acid salts  Azacyclic compounds  Carboxylic acids  Organic metal halides  Organic calcium salts  Monocarboxylic acids and derivatives  Organonitrogen compounds  Organic zwitterions  Organic oxides  Organopnictogen compounds  Hydrocarbon derivatives  Organofluorides  Carbonyl compounds  
Molecular Framework Not available
Substituents 2,3-diphenylpyrrole - Aromatic anilide - Medium-chain hydroxy acid - Pyrrole-3-carboxylic acid or derivatives - Pyrrole-3-carboxamide - Medium-chain fatty acid - Halobenzene - Fluorobenzene - Beta-hydroxy acid - Hydroxy fatty acid - Fatty acyl - Fatty acid - Aryl fluoride - Benzenoid - Aryl halide - Monocyclic benzene moiety - Hydroxy acid - Vinylogous amide - Heteroaromatic compound - Secondary alcohol - Secondary carboxylic acid amide - Carboxylic acid salt - Carboxamide group - Organic calcium salt - Organic metal halide - Carboxylic acid derivative - Carboxylic acid - Azacycle - Monocarboxylic acid or derivatives - Organic salt - Organopnictogen compound - Hydrocarbon derivative - Organic oxygen compound - Organic oxide - Organic nitrogen compound - Carbonyl group - Organic zwitterion - Organooxygen compound - Organonitrogen compound - Alcohol - Organohalogen compound - Organofluoride - Aromatic heteromonocyclic compound
Description This compound belongs to the class of organic compounds known as diphenylpyrroles. These are aromatic heterocyclic compounds with a structure based on a pyrrole ring linked to exactly two phenyl groups.
External Descriptors hydrate - statin (synthetic)

Names and Identifiers

Pubchem Sid 504759788
Pubchem Sid Url https://pubchem.ncbi.nlm.nih.gov/substance/504759788
IUPAC Name calcium;(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate;trihydrate
INCHI InChI=1S/2C33H35FN2O5.Ca.3H2O/c2*1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40;;;;/h2*3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40);;3*1H2/q;;+2;;;/p-2/t2*26-,27-;;;;/m11..../s1
InChIKey SHZPNDRIDUBNMH-NIJVSVLQSA-L
Smiles CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.O.O.O.[Ca+2]
Isomeric SMILES CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.O.O.O.[Ca+2]
Alternate CAS 134523-03-8
Molecular Weight 1155.4(as Anhydrous)
Reaxy-Rn 45453419
Reaxys-RN_link_address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=45453419&ln=

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

4 results found

Lot Number Certificate Type Date Item
D1904072 Certificate of Analysis Jan 09, 2023 A179410
J2122171 Certificate of Analysis Oct 28, 2021 A179410
H2406074 Certificate of Analysis Oct 28, 2021 A179410
E2514623 Certificate of Analysis Oct 28, 2021 A179410

Chemical and Physical Properties

Molecular Weight 1209.400 g/mol
XLogP3
Hydrogen Bond Donor Count 9
Hydrogen Bond Acceptor Count 15
Rotatable Bond Count 22
Exact Mass 1208.48 Da
Monoisotopic Mass 1208.48 Da
Topological Polar Surface Area 232.000 Ų
Heavy Atom Count 86
Formal Charge 0
Complexity 817.000
Isotope Atom Count 0
Defined Atom Stereocenter Count 4
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
The total count of all stereochemical bonds 0
Covalently-Bonded Unit Count 6

Citations of This Product

1. Yinhong Xie, Mengchen Chi, Ruichen Dong, Sui Wu, Jinming Yang, Qin Wang, Junying Chen, Yajun Weng.  (2024)  A multi-target and responsive nanoplatform (MM/ZnS/ATV) combining H2S and atorvastatin for enhanced atherosclerosis therapy.  CHEMICAL ENGINEERING JOURNAL,  495  (153439). 

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.